John R. Penrod

Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee

Paul R. Fortin, John R. Penrod, Ann E. Clarke et al. · Arthritis & Rheumatism · 2002 · 433 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis

Scott Antonia, Hossein Borghaei, Suresh S. Ramalingam et al. · The Lancet Oncology · 2019 · 365 citations · Full text

Medicine, Oncology, Immuno-oncology Pharmacotherapy +7

Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non–small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial

Martin Reck, Michael Schenker, Ki Hyeong Lee et al. · European Journal of Cancer · 2019 · 217 citations · Full text

Medicine, Oncology, Pharmacology +17

Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa

Motasim Badri, Gary Maartens, Sundhiya Mandalia et al. · PLoS Medicine · 2005 · 145 citations · Full text

Pharmacy, Infectious Disease Control, Pharmacoeconomics +17

Health services costs and their determinants in women with fibromyalgia.

John R. Penrod, Sasha Bernatsky, Viviane Adam et al. · PubMed · 2004 · 133 citations

Pharmacy, Internal Medicine, Pharmacoeconomics +17